Design, synthesis, and α1-adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion

被引:19
作者
Betti, L
Floridi, M
Giannaccini, G
Manetti, F
Paparelli, C
Strappaghetti, G
Botta, M
机构
[1] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06123 Perugia, Italy
[2] Univ Pisa, Dipartimento Psichiat Neurobiol Farmacol & Biotec, I-56126 Pisa, Italy
[3] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy
关键词
alpha(1)-adrenoceptor affinity; flavone; pharmacophore; pyridazinone-piperazine;
D O I
10.1016/j.bmc.2003.12.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Following our research project aimed at obtaining new compounds with high affinity and selectivity toward alpha(1)-adrenoceptors (AR), a new class of piperazine derivatives was designed, synthesized and biologically tested. The new compounds 1-13 are characterized by a flavone system linked, through an ethoxy or propoxy spacer, to a phenyl- or pyridazinone-piperazine moiety. Biological data showed an interesting profile for the phenylpiperazine subclass found to have a nanomolar affinity toward alpha(1)-AR, and less pronounced affinity for alpha(2)-AR and the 5-HT1A serotoninergic receptor. A discussion on the structure-activity relationship (SAR) of such compounds is also reported, on the basis of the flavone substitution pattern, length and functionalization of the spacer, and disruption of the phenylpiperazine system. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1527 / 1535
页数:9
相关论文
共 15 条
[1]   Synthesis and biological activity of new 1,4-benzodioxanarylpiperazine derivatives.: Further validation of a pharmacophore model for α1-adrenoceptor antagonists [J].
Barbaro, R ;
Betti, L ;
Botta, M ;
Corelli, F ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Corsano, S .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (02) :361-369
[2]   Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward α1- and α2-adrenoceptors [J].
Barbaro, R ;
Betti, L ;
Botta, M ;
Corelli, F ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Corsano, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (13) :2118-2132
[3]   α1-adrenoceptor antagonists.: 6.: structural optimization of pyridazinone-arylpiperazines.: Study of the influence on affinity and selectivity of cyclic substituents at the pyridazinone ring and alkoxy groups at the arylpiperazine moiety [J].
Betti, L ;
Corelli, F ;
Floridi, M ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Botta, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (16) :3555-3558
[4]   α1-adrenoceptor antagonists.: 4.: Pharmacophore-based design, synthesis, and biological evaluation of new imidazo-, benzimidazo-, and indoloarylpiperazine derivatives [J].
Betti, L ;
Botta, M ;
Corelli, F ;
Floridi, M ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Tafi, A ;
Corsano, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3603-3611
[5]   α1-adrenoceptor antagonists.: 5.: Pyridazinone-arylpiperazines.: Probing the influence on affinity and selectivity of both ortho-alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus [J].
Betti, L ;
Floridi, M ;
Giannaccini, G ;
Manetti, F ;
Strappaghetti, G ;
Tafi, A ;
Botta, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (02) :171-173
[6]  
BOURDAIS J, 1968, B SOC CHIM FR, P3246
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]  
EDWIN SC, 1992, J MED CHEM, V35, P3519
[9]   ACTIVITY OF AROMATIC SUBSTITUTED PHENYLPIPERAZINES LACKING AFFINITY FOR DOPAMINE BINDING-SITES IN A PRECLINICAL TEST OF ANTIPSYCHOTIC EFFICACY [J].
MARTIN, GE ;
ELGIN, RJ ;
MATHIASEN, JR ;
DAVIS, CB ;
KESSLICK, JM ;
BALDY, WJ ;
SHANK, RP ;
DISTEFANO, DL ;
FEDDE, CL ;
SCOTT, MK .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (05) :1052-1056
[10]   Structure-activity relationship studies of CNS agents .32. Effect of structural modifications in 1-arylpiperazine derivatives on alpha(1)-adrenoreceptor affinity [J].
Mokrosz, MJ ;
Paluchowska, MH ;
CharakchievaMinol, S ;
Bien, A .
ARCHIV DER PHARMAZIE, 1997, 330 (06) :177-180